The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death.
Haam S, Lee S, Paik HC, Park MS, Song JH, Lim BJ, Nakao A · European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2015
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
The publication “The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death.” is organized in H2HUBB under the research focus hydrogen inhalation cardiovascular health study 2015. The publication is cited as Haam S, Lee S, Paik HC, Park MS, Song JH, Lim BJ, Nakao A, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2015. This animal study examined The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death. The abstract describes Animal model; sample size 5; hydrogen delivered as hydrogen inhalation. The abstract reports: Hydrogen gas inhalation during EVLP improved the function of DCD lungs, which may increase the utilization of DCD lungs. This is an automated editorial draft based on the abstract and requires source review before publication.
Hydrogen inhalation cardiovascular health study 2015 overview
Lung transplantation is a well-established treatment of end-stage lung disease; however, it is limited by a shortage of donor lungs. To overcome this problem,… Animal research can identify biological effects and support future investigation, but it cannot by itself establish safety or effectiveness in humans.
Study design and hydrogen intervention
Publication type: Animal study. Evidence type: Preclinical animal evidence. Research model or population: Porcine donor-lung ex vivo perfusion model. Sample size: 5. Randomized: Yes. Blinding: Unknown. Control status: Control group reported.
Delivery method: Hydrogen inhalation.
Reported findings and scientific interpretation
For this hydrogen inhalation cardiovascular health study 2015, the study record reports the following: The abstract reports: Hydrogen gas inhalation during EVLP improved the function of DCD lungs, which may increase the utilization of DCD lungs.
These findings should be interpreted as one piece of evidence rather than as a stand-alone medical conclusion. Results can be influenced by the research model, study design, treatment protocol, sample size, outcome selection, statistical methods, and whether the findings have been independently reproduced.
How this research record was prepared
H2HUBB organizes bibliographic details, study design information, intervention data, outcomes, limitations, and safety notes from the available scientific source. Automated classification supports database organization, but it does not replace critical reading of the complete paper. Source identifiers, evidence labels, and delivery-method fields are retained so readers can verify the record and compare it with related publications. A missing field means the information was unavailable or not reported in the structured source; it should not be treated as a negative finding.
Limitations, safety, and original source
Limitations: Preclinical animal findings may not translate directly to human outcomes.
Lung transplantation is a well-established treatment of end-stage lung disease; however, it is limited by a shortage of donor lungs.
Safety: The abstract did not provide detailed safety or adverse-event information.
This H2HUBB page is an educational research record, not medical advice. Review the original scientific source for the complete methods and results. Continue exploring the H2HUBB Molecular Hydrogen Research Library to compare evidence types, delivery methods, and related topics.